-
サマリー
あらすじ・解説
In this episode, we dive into the lives of patients with hypertrophic cardiomyopathy (HCM) and how Aficamten is offering them hope for a better future. From breathing easier to avoiding surgery, we’ll uncover the real impact of this new treatment backed by the SEQUOIA-HCM trial. If you care about heart health or know someone living with HCM, this one’s for you.
Links to the Podcast
- Apple Podcast:Listen on Apple Podcast
- Spotify:Listen on Spotify
- Amazon Music:Listen on Amazon Music
- YouTube:Watch on YouTube
📝Source:
Study Title: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (SEQUOIA-HCM Trial)
Publication Date: May 13, 2024
NEJM.org - SEQUOIA-HCM Trial
🔗Full Study Details:NEJM - SEQUOIA-HCM Study
🔗ClinicalTrials.gov:SEQUOIA-HCM NCT05186818
#BreathingEasier #HeartHealth #Aficamten #NewHope #SEQUOIAHCM #CardiologyTalk #Podcast #RealImpact #MedicalBreakthroughs #BetterLiving